How hydrogen bonds impact P-glycoprotein transport and permeability

被引:114
作者
Desai, Prashant V. [2 ]
Raub, Thomas J. [2 ]
Blanco, Maria-Jesus [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Lilly Res Labs, Drug Disposit, Computat ADME, Indianapolis, IN 46285 USA
关键词
Hydrogen bond; Intramolecular hydrogen bond; P-Glycoprotein; Permeability; HBA; HBD; TPSA; ATP-binding cassette; CENTRAL-NERVOUS-SYSTEM; SPINDLE PROTEIN KSP; PASSIVE MEMBRANE-PERMEABILITY; BLOOD-BRAIN-BARRIER; DRUG DESIGN; RECEPTOR ANTAGONISTS; PEPTIDE STRUCTURE; CACO-2; CELLS; IN-VITRO; INHIBITORS;
D O I
10.1016/j.bmcl.2012.08.059
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The requirement to cross a biological membrane can be a complex process especially if multidrug transporters such as P-gp must be considered. Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role. All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength. Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramolecular H-bonds to increase membrane permeability and/or decrease P-gp efflux. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6540 / 6548
页数:9
相关论文
共 66 条
[1]   P-glycoprotein senses its substrates and the lateral membrane packing density:: Consequences for the catalytic cycle [J].
Aanismaa, Paivi ;
Gatlik-Landwojtowicz, Ewa ;
Seelig, Anna .
BIOCHEMISTRY, 2008, 47 (38) :10197-10207
[3]   HYDROGEN-BONDING .9. SOLUTE PROTON DONOR AND PROTON ACCEPTOR SCALES FOR USE IN DRUG DESIGN [J].
ABRAHAM, MH ;
DUCE, PP ;
PRIOR, DV ;
BARRATT, DG ;
MORRIS, JJ ;
TAYLOR, PJ .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1989, (10) :1355-1375
[4]   Application of hydrogen bonding calculations in property based drug design [J].
Abraham, MH ;
Ibrahim, A ;
Zissimos, AM ;
Zhao, YH ;
Comer, J ;
Reynolds, DP .
DRUG DISCOVERY TODAY, 2002, 7 (20) :1056-1063
[5]   Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space [J].
Alex, Alexander ;
Millan, David S. ;
Perez, Manuel ;
Wakenhut, Florian ;
Whitlock, Gavin A. .
MEDCHEMCOMM, 2011, 2 (07) :669-674
[6]   Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist [J].
Ashwood, VA ;
Field, MJ ;
Horwell, DC ;
Julien-Larose, C ;
Lewthwaite, RA ;
McCleary, S ;
Pritchard, MC ;
Raphy, J ;
Singh, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (14) :2276-2285
[7]   Exploring the P-Glycoprotein Binding Cavity with Polyoxyethylene Alkyl Ethers [J].
Blatter, Xiaochun Li ;
Seelig, Anna .
BIOPHYSICAL JOURNAL, 2010, 99 (11) :3589-3598
[8]   A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder [J].
Callegari, Ernesto ;
Malhotra, Bimal ;
Bungay, Peter J. ;
Webster, Rob ;
Fenner, Katherine S. ;
Kempshall, Sarah ;
LaPerle, Jennifer L. ;
Michel, Martin C. ;
Kay, Gary G. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (02) :235-246
[9]  
Clark DE, 2011, FUTURE MED CHEM, V3, P469, DOI [10.4155/fmc.11.1, 10.4155/FMC.11.1]
[10]   Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic Potentials [J].
Colabufo, Nicola Antonio ;
Berardi, Francesco ;
Cantore, Mariangela ;
Contino, Marialessandra ;
Inglese, Carmela ;
Niso, Mauro ;
Perrone, Roberto .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) :1883-1897